Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson's Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia, adult attention deficit hyperactivity disorder (ADHD), chronic fatigue syndrome (CFS), freezing of gait in PD and Down syndrome. In addition, the Company is developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis and is exploring potential applications in multiple other autoimmune disorders.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:CHTP
- CUSIP: N/A
- Web: N/A
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -21.03
- P/E Growth: 0
Frequently Asked Questions for Chelsea Therapeutics International (NASDAQ:CHTP)
What is Chelsea Therapeutics International's stock symbol?
Chelsea Therapeutics International trades on the NASDAQ under the ticker symbol "CHTP."
Who are some of Chelsea Therapeutics International's key competitors?
Some companies that are related to Chelsea Therapeutics International include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Regeneron Pharmaceuticals (REGN), Merck KGaA (MKGAY), CIGNA (CI), Shire PLC (SHP), Fresenius Medical Care AG & Co. (FMS), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), Veeva Systems (VEEV), West Pharmaceutical Services (WST), Bioverativ (BIVV), ABIOMED (ABMD), ConvaTec Group PLC (CTEC), Mediclinic International PLC (MDC) and Health Net (HNT).
How do I buy Chelsea Therapeutics International stock?
Shares of Chelsea Therapeutics International can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chelsea Therapeutics International's stock price today?
MarketBeat Community Rating for Chelsea Therapeutics International (NASDAQ CHTP)MarketBeat's community ratings are surveys of what our community members think about Chelsea Therapeutics International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Chelsea Therapeutics International stock can currently be purchased for approximately $6.52.
Consensus Ratings for Chelsea Therapeutics International (NASDAQ:CHTP) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Chelsea Therapeutics International (NASDAQ:CHTP)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Chelsea Therapeutics International (NASDAQ:CHTP)Earnings History by Quarter for Chelsea Therapeutics International (NASDAQ CHTP)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Chelsea Therapeutics International (NASDAQ:CHTP)
Current Year EPS Consensus Estimate: $-0.46 EPS
Next Year EPS Consensus Estimate: $-0.31 EPS
Dividend History for Chelsea Therapeutics International (NASDAQ:CHTP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Chelsea Therapeutics International (NASDAQ:CHTP)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Chelsea Therapeutics International (NASDAQ:CHTP)
Latest Headlines for Chelsea Therapeutics International (NASDAQ:CHTP)
Chelsea Therapeutics International (CHTP) Chart for Saturday, July, 22, 2017